{
    "info": {
        "nct_id": "NCT04411641",
        "official_title": "A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis",
        "inclusion_criteria": "Inclusion criteria :\n\n* 18 to 60 years of age inclusive\n* Diagnosis of nonrelapsing secondary progressive multiple sclerosis according to the 2017 McDonald criteria\n* Expanded disability status scale (EDSS) between 3.0 to 6.5 points inclusive, at screening\n* The participant must have documented evidence of disability progression observed during the 12 months before screening\n* Absence of clinical relapses for at least 24 months\n* Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies\n* A female participant is eligible to participate if she is not pregnant or breastfeeding, and at least one of the following conditions applies:\n* Is not a WOCBP OR\n* Is a WOCBP and agrees to use an acceptable contraceptive method\n\nExclusion criteria:\n\n* The participant has conditions that would adversely affect study participation such as short life expectancy.\n* History of organ transplant.\n* Evidence of infection with human immuodeficiency virus (HIV), transplantation, progressive multifocal leukoencephalopathy (PML), active hepatitis B or C, active or latent tuberculosis or other active infections that would adversely affect study participation.\n* Persistent chronic or active or recurring system infection, that may adversely affect participation or IMP administration in this study, as judged by the Investigator.\n* History of malignancy within 5 years prior to screening.\n* History of alcohol or drug abuse within 1 year prior to screening.\n* Hospitalized for psychiatric disease within 2 years prior to screening.\n* Clinically significant laboratory abnormalities (including evidence of liver injury) or electrocardiogram abnormalities at screening\n* Bleeding disorder, known platelet dysfunctionat any time prior to the screening visit\n* A platelet count <150 000/Î¼L at the screening visit\n* A history of significant bleeding event within 6 months prior to screening, according to the Investigator's judgment such as, but not limited to cerebral or gastrointestinal bleeding.\n* Lymphocyte count below the lower limit of normal at screening.\n* Recent live (attenuated) vaccine within 2 months before the first treatment visit.\n* Recent major surgery (within 4 weeks of screening) or planned major surgery during the study.\n* The participant has received medications/treatments for MS within a specified time frame.\n* Receiving potent and moderate inducers or inhibitors of cytochrome P450 3A (CYP3A) or potent inhibitors of CYP2C8 hepatic enzymes.\n* Receiving anticoagulant or antiplatelet therapy (such as aspirin>81mg/day, clopidogrel, warfarin).\n* Contraindications to magnetic resonance imaging (MRI).\n\nThe above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 60 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Diagnosis of nonrelapsing secondary progressive multiple sclerosis according to the 2017 McDonald criteria",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of nonrelapsing secondary progressive multiple sclerosis",
                    "criterion": "secondary progressive multiple sclerosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "relapsing status",
                            "expected_value": "nonrelapsing"
                        }
                    ]
                },
                {
                    "exact_snippets": "according to the 2017 McDonald criteria",
                    "criterion": "diagnosis criteria",
                    "requirements": [
                        {
                            "requirement_type": "criteria used",
                            "expected_value": "2017 McDonald criteria"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically significant laboratory abnormalities (including evidence of liver injury) or electrocardiogram abnormalities at screening",
            "criterions": [
                {
                    "exact_snippets": "Clinically significant laboratory abnormalities (including evidence of liver injury)",
                    "criterion": "laboratory abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of liver injury",
                    "criterion": "liver injury",
                    "requirements": [
                        {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "electrocardiogram abnormalities at screening",
                    "criterion": "electrocardiogram abnormalities",
                    "requirements": [
                        {
                            "requirement_type": "presence at screening",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindications to magnetic resonance imaging (MRI).",
            "criterions": [
                {
                    "exact_snippets": "Contraindications to magnetic resonance imaging (MRI)",
                    "criterion": "contraindications to MRI",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of malignancy within 5 years prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "History of malignancy within 5 years prior to screening.",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years prior to screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* 18 to 60 years of age inclusive",
            "criterions": [
                {
                    "exact_snippets": "18 to 60 years of age inclusive",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 18,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 60,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A history of significant bleeding event within 6 months prior to screening, according to the Investigator's judgment such as, but not limited to cerebral or gastrointestinal bleeding.",
            "criterions": [
                {
                    "exact_snippets": "A history of significant bleeding event within 6 months prior to screening",
                    "criterion": "significant bleeding event",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "according to the Investigator's judgment such as, but not limited to cerebral or gastrointestinal bleeding",
                    "criterion": "type of bleeding event",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "cerebral",
                                "gastrointestinal"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Recent live (attenuated) vaccine within 2 months before the first treatment visit.",
            "criterions": [
                {
                    "exact_snippets": "Recent live (attenuated) vaccine within 2 months before the first treatment visit.",
                    "criterion": "live (attenuated) vaccine administration",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "months before the first treatment visit"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receiving anticoagulant or antiplatelet therapy (such as aspirin>81mg/day, clopidogrel, warfarin).",
            "criterions": [
                {
                    "exact_snippets": "Receiving anticoagulant or antiplatelet therapy (such as aspirin>81mg/day, clopidogrel, warfarin)",
                    "criterion": "anticoagulant therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Receiving anticoagulant or antiplatelet therapy (such as aspirin>81mg/day, clopidogrel, warfarin)",
                    "criterion": "antiplatelet therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "aspirin>81mg/day",
                    "criterion": "aspirin dosage",
                    "requirements": [
                        {
                            "requirement_type": "dosage",
                            "expected_value": {
                                "operator": ">",
                                "value": 81,
                                "unit": "mg/day"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "clopidogrel",
                    "criterion": "clopidogrel therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "warfarin",
                    "criterion": "warfarin therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 60 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 60 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Lymphocyte count below the lower limit of normal at screening.",
            "criterions": [
                {
                    "exact_snippets": "Lymphocyte count below the lower limit of normal at screening",
                    "criterion": "lymphocyte count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 0,
                                "unit": "lower limit of normal"
                            }
                        },
                        {
                            "requirement_type": "timepoint",
                            "expected_value": "at screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Is not a WOCBP OR",
            "criterions": [
                {
                    "exact_snippets": "Is not a WOCBP",
                    "criterion": "woman of childbearing potential (WOCBP) status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Expanded disability status scale (EDSS) between 3.0 to 6.5 points inclusive, at screening",
            "criterions": [
                {
                    "exact_snippets": "Expanded disability status scale (EDSS) between 3.0 to 6.5 points inclusive, at screening",
                    "criterion": "Expanded Disability Status Scale (EDSS) score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3.0,
                                        "unit": "points"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 6.5,
                                        "unit": "points"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of alcohol or drug abuse within 1 year prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "History of alcohol or drug abuse within 1 year prior to screening.",
                    "criterion": "alcohol abuse",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year prior to screening"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of alcohol or drug abuse within 1 year prior to screening.",
                    "criterion": "drug abuse",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "year prior to screening"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Is a WOCBP and agrees to use an acceptable contraceptive method",
            "criterions": [
                {
                    "exact_snippets": "Is a WOCBP",
                    "criterion": "woman of childbearing potential (WOCBP)",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "agrees to use an acceptable contraceptive method",
                    "criterion": "contraceptive method use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "acceptability",
                            "expected_value": "acceptable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A female participant is eligible to participate if she is not pregnant or breastfeeding, and at least one of the following conditions applies:",
            "criterions": [
                {
                    "exact_snippets": "female participant ... is not pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnancy",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "female participant ... is not ... breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "breastfeeding",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Persistent chronic or active or recurring system infection, that may adversely affect participation or IMP administration in this study, as judged by the Investigator.",
            "criterions": [
                {
                    "exact_snippets": "Persistent chronic or active or recurring system infection",
                    "criterion": "system infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "persistence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recurrence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "that may adversely affect participation or IMP administration in this study, as judged by the Investigator",
                    "criterion": "potential to adversely affect participation or IMP administration",
                    "requirements": [
                        {
                            "requirement_type": "risk assessment",
                            "expected_value": "as judged by the Investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A platelet count <150 000/Î¼L at the screening visit",
            "criterions": [
                {
                    "exact_snippets": "A platelet count <150 000/Î¼L at the screening visit",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 150000,
                                "unit": "/Î¼L"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of infection with human immuodeficiency virus (HIV), transplantation, progressive multifocal leukoencephalopathy (PML), active hepatitis B or C, active or latent tuberculosis or other active infections that would adversely affect study participation.",
            "criterions": [
                {
                    "exact_snippets": "Evidence of infection with human immuodeficiency virus (HIV)",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "transplantation",
                    "criterion": "history of transplantation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "progressive multifocal leukoencephalopathy (PML)",
                    "criterion": "progressive multifocal leukoencephalopathy (PML)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active hepatitis B or C",
                    "criterion": "active hepatitis B or C infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active or latent tuberculosis",
                    "criterion": "tuberculosis infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": [
                                "active",
                                "latent"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "other active infections that would adversely affect study participation",
                    "criterion": "other active infections",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "impact on study participation",
                            "expected_value": "would adversely affect"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Recent major surgery (within 4 weeks of screening) or planned major surgery during the study.",
            "criterions": [
                {
                    "exact_snippets": "Recent major surgery (within 4 weeks of screening)",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "timing_context",
                            "expected_value": "prior to screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "planned major surgery during the study",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing_context",
                            "expected_value": "during the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receiving potent and moderate inducers or inhibitors of cytochrome P450 3A (CYP3A) or potent inhibitors of CYP2C8 hepatic enzymes.",
            "criterions": [
                {
                    "exact_snippets": "Receiving potent and moderate inducers or inhibitors of cytochrome P450 3A (CYP3A)",
                    "criterion": "concomitant medication affecting CYP3A",
                    "requirements": [
                        {
                            "requirement_type": "use of potent or moderate inducers or inhibitors",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Receiving ... potent inhibitors of CYP2C8 hepatic enzymes",
                    "criterion": "concomitant medication affecting CYP2C8",
                    "requirements": [
                        {
                            "requirement_type": "use of potent inhibitors",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The participant has received medications/treatments for MS within a specified time frame.",
            "criterions": [
                {
                    "exact_snippets": "has received medications/treatments for MS within a specified time frame",
                    "criterion": "medications/treatments for MS",
                    "requirements": [
                        {
                            "requirement_type": "receipt within time frame",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absence of clinical relapses for at least 24 months",
            "criterions": [
                {
                    "exact_snippets": "Absence of clinical relapses for at least 24 months",
                    "criterion": "clinical relapses",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 24,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hospitalized for psychiatric disease within 2 years prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "Hospitalized for psychiatric disease within 2 years prior to screening.",
                    "criterion": "psychiatric disease hospitalization",
                    "requirements": [
                        {
                            "requirement_type": "history within timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of organ transplant.",
            "criterions": [
                {
                    "exact_snippets": "History of organ transplant.",
                    "criterion": "organ transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies",
            "criterions": [
                {
                    "exact_snippets": "Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies",
                    "criterion": "contraceptive use",
                    "requirements": [
                        {
                            "requirement_type": "consistency with local regulations",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The participant has conditions that would adversely affect study participation such as short life expectancy.",
            "criterions": [
                {
                    "exact_snippets": "conditions that would adversely affect study participation",
                    "criterion": "conditions adversely affecting study participation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "short life expectancy",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": "short"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The participant must have documented evidence of disability progression observed during the 12 months before screening",
            "criterions": [
                {
                    "exact_snippets": "documented evidence of disability progression observed during the 12 months before screening",
                    "criterion": "disability progression",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months before screening"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.",
            "criterions": []
        },
        {
            "line": "* Bleeding disorder, known platelet dysfunctionat any time prior to the screening visit",
            "criterions": [
                {
                    "exact_snippets": "Bleeding disorder",
                    "criterion": "bleeding disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known platelet dysfunction at any time prior to the screening visit",
                    "criterion": "platelet dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": "any time prior to the screening visit"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Inclusion criteria :",
            "criterions": []
        },
        {
            "line": "Exclusion criteria:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}